TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

Rhea-AI Summary

TScan Therapeutics, Inc. (TCRX) will participate in the Cell Therapy Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference. The event will be held on March 6, 2024, at 9:10 a.m. Eastern Time in Boston. A webcast of the panel discussion will be available on the company's website.

WALTHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that the Company will participate in the Cell Therapy Corporate Panel Discussion at the TD Cowen 44^th Annual Health Care Conference being held at the Marriott Copley Place in Boston on Wednesday, March 6, 2024 at 9:10 a.m. Eastern Time.

A webcast of the panel discussion will be available on the “Events and Presentations” section of the Company’s website at ir.tscan.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the event.

About TScan Therapeutics, Inc.

TScan is a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The Company’s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to expand its ImmunoBank, the Company’s repository of therapeutic TCRs that recognize diverse targets and are associated with multiple HLA types, to provide customized, enhanced, multiplexed TCR-T therapies for patients with a variety of cancers.

Contacts

Heather Savelle
TScan Therapeutics, Inc.
VP, Investor Relations
857-399-9840
hsavelle@tscan.com

Joyce Allaire
LifeSci Advisors, LLC
Managing Director
617-435-6602
jallaire@lifesciadvisors.com

FAQ

When will TScan Therapeutics, Inc. participate in the Cell Therapy Corporate Panel Discussion?

TScan Therapeutics, Inc. (TCRX) will participate in the Cell Therapy Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference on March 6, 2024, at 9:10 a.m. Eastern Time.

Where will the event be held?

The event will be held at the Marriott Copley Place in Boston.

Where can I watch the webcast of the panel discussion?

A webcast of the panel discussion will be available on the 'Events and Presentations' section of the Company’s website at ir.tscan.com.

How long will the archived replay of the webcast be available?

An archived replay of the webcast will be available on the Company’s website for 30 days following the event.